Randomized, double-blind study with glycerol and paraffin in uremic xerosis.
OBJECTIVE
Uremic xerosis is a bothersome condition that is poorly responsive to moisturizing and emollient therapy.


METHODS
A randomized, double-blind, intraindividual (left versus right comparison), multicentric clinical study was performed on 100 patients with moderate to severe uremic xerosis for 7 days, during which the patients applied twice daily an emulsion combining glycerol and paraffin (test product) on one allocated lower leg, and the emulsion alone (comparator) on the other lower leg. This was followed by an open-labeled use of the test product on all of the xerotic areas for 49 days. The main efficacy parameter was treatment response on each lower leg, as defined by a reduction from baseline of at least two grades in a five-point clinical score on day 7.


RESULTS
Among the 99 patients analyzed, the test product was highly effective with a treatment response in 72 patients (73%), whereas 44 patients (44%) responded to the comparator (P<0.0001, intergroup analysis). This was associated with an objective reduction in the density and thickness of the scales on day 7 (P<0.0001 compared with the comparator) and a substantial improvement of the uremic pruritus (75%) and quality of life of the patients at study end (P<0.001, intragroup analysis). The test product was very well tolerated, with product-related local intolerance (exacerbated pruritus, local burning, or erythema) occurring in only five patients (5%).


CONCLUSIONS
Uremic xerosis can be managed successfully when an appropriate emollient therapy is used.
Department of Nephrology, Ahepa University Hospital, Thessaloniki, Greece.
Elias
E
Balaskas
Jacek C
JC
Szepietowski
Didier
D
Bessis
Dimitrios
D
Ioannides
Claudio
C
Ponticelli
Corinne
C
Ghienne
Alain
A
Taberly
Patrick
P
Dupuy
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004311:Double-Blind Method; D004643:Emollients / Q000627:therapeutic use*; D005260:Female; D005990:Glycerol / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010232:Paraffin / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D012871:Skin Diseases / Q000188:drug therapy* / Q000209:etiology; D014511:Uremia / Q000150:complications*
D004643:Emollients; D010232:Paraffin; D005990:Glycerol
Int J Cosmet Sci. 2000 Feb;22(1):53-65
18503461
J Biol Chem. 2002 May 10;277(19):17147-53
11880378
Contact Dermatitis. 2001 Feb;44(2):123-5
11205397
Nephrol Dial Transplant. 2004 Nov;19(11):2709-12
15328388
Clin Exp Dermatol. 1994 May;19(3):210-6
8033378
Arch Dermatol Res. 1995;287(5):457-64
7625857
Nephrol Dial Transplant. 1996 Oct;11(10):2031-6
8918718
Dermatology. 1997;194(3):247-50
9187842
Acta Derm Venereol. 1993 Dec;73(6):404-6
7906448
Acta Derm Venereol. 1999 Nov;79(6):418-21
10598752
J Dermatol. 2002 Oct;29(10):621-7
12432992
Clin Exp Dermatol. 1996 Sep;21(5):338-43
9136151
Med J Aust. 1987 Apr 6;146(7):397, 400
3561302
Int J Cosmet Sci. 1986 Dec;8(6):253-64
19457222
Br J Dermatol. 2003 Feb;148(2):314-7
12588385
Perit Dial Int. 1993;13 Suppl 2:S527-32
8399656
Nephrol Dial Transplant. 2007 Nov;22(11):3268-72
17595180
Dermatology. 2000;200(4):308-13
10894961
Arch Dermatol. 1982 Mar;118(3):154-6
7065661
J Dermatolog Treat. 2001 Sep;12(3):181; author reply 182
12243713
Acta Derm Venereol. 1998 Jul;78(4):270-3
9689294